Novel Diphenylamine Analogs Induce Mesenchymal to Epithelial Transition in Triple Negative Breast Cancer

Frontiers in Oncology- Switzerland

doi 10.3389/fonc.2019.00672

Full Text

Abstract

Available in

Date

Authors

Publisher

Frontiers Media SA

Related search

An in Vitro–in Vivo Model of Epithelial Mesenchymal Transition in Triple Negative Breast Cancer

Drug Discovery Today: Disease Mechanisms
2012English

miR‑30a Inhibits Epithelial‑mesenchymal Transition and Metastasis in Triple‑negative Breast Cancer by Targeting ROR1

Oncology Reports
MedicineCancer ResearchOncology
2018English

CD155 Contributes to the Mesenchymal Phenotype of Triple‐negative Breast Cancer

Cancer Science
Cancer ResearchMedicineOncology
2020English

Host Microenvironment in Breast Cancer Development: Epithelial–mesenchymal Transition in Breast Cancer Development

Breast Cancer Research
Cancer ResearchOncology
2003English

Loss of CLCA4 Promotes Epithelial-To-Mesenchymal Transition in Breast Cancer Cells

PLoS ONE
Multidisciplinary
2013English

Panepoxydone Targets NF-kB and FOXM1 to Inhibit Proliferation, Induce Apoptosis and Reverse Epithelial to Mesenchymal Transition in Breast Cancer

PLoS ONE
Multidisciplinary
2014English

Epithelial-Mesenchymal Transition and Drug Resistance in Breast Cancer (Review)

International Journal of Oncology
Cancer ResearchOncology
2015English

Interleukin-6 Induces Epithelial-Mesenchymal Transition in Breast Cancer Cells

Gaceta Mexicana de Oncolog�a
2019English

Epithelial-Mesenchymal Transition—A Hallmark of Breast Cancer Metastasis

Cancer Hallmarks
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy